Sigma Metric Analysis

Continuing in our analysis of hematology systems, we look at the impact of new CLIA and EFLM goals on the assessment of the Mindray BC 7500 instrument.

For over a year, we've been looking at the impact of new CLIA and EFLM goals on the assessment of biochemistry instruments. Well, the goals for hematology have changed as well. How does a Sysmex XN 350 fare when judged by the latest goals for CLIA and EFLM

What happened to laboratory quality during the pandemic? There's what we suspect, and what we can actually quantify. A laboratory in India made the ultimate assessment: they collected data on their VITROS 5600 both before and during their COVID lockdown. The results are serious. Looking through the lens of EFLM and CLIA goals, it's even more serious.

Multimode analysis isn't just for chemistry assays. It's time to look at immunoassay performance from the major diagnostic manufacturers. IA is an area where the goal differences get bigger. As EFLM gets wider and CLIA gets tighter, the impacts in IA are also important. This time we look at a Roche cobas 6000, with a evaluation of measurement uncertainty as the cherry on top.